Johnson & Johnson's Zytiga Helps Increase Survival Rate For Patient With Severe Prostate Cancer Medicine & Technology Jun 05, 2017 American Society of Clinical Oncology (ASCO) presented the research of the effectiveness of Zytiga to boost the survival rate for severe prostate cancers.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts